136 related articles for article (PubMed ID: 19712626)
1. Long-term bosentan treatment of complex congenital heart disease and Eisenmenger's syndrome.
Díaz-Caraballo E; González-García AE; Reñones M; Sánchez-Recalde A; García-Río F; Oliver-Ruiz JM
Rev Esp Cardiol; 2009 Sep; 62(9):1046-9. PubMed ID: 19712626
[TBL] [Abstract][Full Text] [Related]
2. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease.
Diller GP; Dimopoulos K; Kaya MG; Harries C; Uebing A; Li W; Koltsida E; Gibbs JS; Gatzoulis MA
Heart; 2007 Aug; 93(8):974-6. PubMed ID: 17639112
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of treatment with bosentan in adult Eisenmenger's syndrome patients with Down's syndrome related to congenital heart disease.
Crepaz R; Romeo C; Montanaro D; De Santis S
BMC Cardiovasc Disord; 2013 Sep; 13():74. PubMed ID: 24047157
[TBL] [Abstract][Full Text] [Related]
4. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease.
Kotlyar E; Sy R; Keogh AM; Kermeen F; Macdonald PS; Hayward CS; McNeil KD; Celermajer DS
Cardiol Young; 2006 Jun; 16(3):268-74. PubMed ID: 16725066
[TBL] [Abstract][Full Text] [Related]
5. [The effect of an endothelin receptor antagonist in Eisenmenger syndrome: a single-center experience of 11 patients].
Poindron D; Godart F; Duhamel A; Richard A; Francart C; Brevière GM; Rey C
Arch Mal Coeur Vaiss; 2006 May; 99(5):457-62. PubMed ID: 16802735
[TBL] [Abstract][Full Text] [Related]
6. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.
Galie N; Manes A; Palazzini M; Negro L; Marinelli A; Gambetti S; Mariucci E; Donti A; Branzi A; Picchio FM
Drugs; 2008; 68(8):1049-66. PubMed ID: 18484798
[TBL] [Abstract][Full Text] [Related]
7. Initial experience with bosentan therapy in patients with the Eisenmenger syndrome.
Christensen DD; McConnell ME; Book WM; Mahle WT
Am J Cardiol; 2004 Jul; 94(2):261-3. PubMed ID: 15246919
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of bosentan in adults with simple and complex Eisenmenger's syndrome.
Williams R; Houser L; Miner P; Aboulhosn J
Congenit Heart Dis; 2012; 7(1):12-5. PubMed ID: 22188797
[TBL] [Abstract][Full Text] [Related]
9. Changes in exercise capacity and cardiac performance in a series of patients with Eisenmenger's syndrome transitioned from selective to dual endothelin receptor antagonist.
Kopeć G; Tyrka A; Miszalski-Jamka T; Mikołajczyk T; Waligóra M; Guzik T; Podolec P
Heart Lung Circ; 2012 Nov; 21(11):671-8. PubMed ID: 22819097
[TBL] [Abstract][Full Text] [Related]
10. Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
Mehta PK; Simpson L; Lee EK; Lyle TA; McConnell ME; Book WM
Tex Heart Inst J; 2008; 35(3):256-61. PubMed ID: 18941642
[TBL] [Abstract][Full Text] [Related]
11. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.
Galiè N; Beghetti M; Gatzoulis MA; Granton J; Berger RM; Lauer A; Chiossi E; Landzberg M;
Circulation; 2006 Jul; 114(1):48-54. PubMed ID: 16801459
[TBL] [Abstract][Full Text] [Related]
12. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C
Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545
[TBL] [Abstract][Full Text] [Related]
13. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study.
Gatzoulis MA; Beghetti M; Galiè N; Granton J; Berger RM; Lauer A; Chiossi E; Landzberg M;
Int J Cardiol; 2008 Jun; 127(1):27-32. PubMed ID: 17658633
[TBL] [Abstract][Full Text] [Related]
14. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
[TBL] [Abstract][Full Text] [Related]
15. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.
Berger RM; Beghetti M; Galiè N; Gatzoulis MA; Granton J; Lauer A; Chiossi E; Landzberg M
Int J Cardiol; 2010 Oct; 144(3):373-8. PubMed ID: 19464064
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of sildenafil in Eisenmenger's syndrome secondary to atrial septal defect versus ventricular septal defect: a cardiac catheterisation follow-up study.
Garg N; Tripathy N; Sinha N
Cardiol Young; 2011 Dec; 21(6):631-8. PubMed ID: 21729508
[TBL] [Abstract][Full Text] [Related]
17. Treatment of patients with Eisenmenger's syndrome with Bosentan.
Brun H; Thaulow E; Fredriksen PM; Holmstrom H
Cardiol Young; 2007 Jun; 17(3):288-94. PubMed ID: 17451611
[TBL] [Abstract][Full Text] [Related]
18. [Remarkable response of bosentan, an endothelin receptor antagonist, for a patient with Eisenmenger syndrome].
Emoto N; Matsuo N; Ohnishi T; Miyagawa K; Kato H; Iwasa N; Yoshida A; Kawai H; Hirata K; Kuroda Y
Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2549-51. PubMed ID: 19051748
[No Abstract] [Full Text] [Related]
19. Down patients with Eisenmenger syndrome: is bosentan treatment an option?
Duffels MG; Vis JC; van Loon RL; Berger RM; Hoendermis ES; van Dijk AP; Bouma BJ; Mulder BJ
Int J Cardiol; 2009 May; 134(3):378-83. PubMed ID: 18579234
[TBL] [Abstract][Full Text] [Related]
20. Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect.
D'Alto M; Vizza CD; Romeo E; Badagliacca R; Santoro G; Poscia R; Sarubbi B; Mancone M; Argiento P; Ferrante F; Russo MG; Fedele F; Calabrò R
Heart; 2007 May; 93(5):621-5. PubMed ID: 17135220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
